- Exchange: Korea SE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
Hanmi Pharm Co Ltd
+ Add to Watchlist128940:KS
167,500 KRW 500 0.30%As of 02:17:24 ET on 06/19/2013.
Snapshot for Hanmi Pharm Co Ltd (128940)
| Open: | 168,000 | Day's Range: | 165,500 - 169,500 | Volume: | 32,429 |
|---|---|---|---|---|---|
| Previous Close: | 168,000 | 52wk Range: | 57,619 - 181,500 | 1-Yr Rtn: | +189.27% |
Key Statistics for 128940
| Current P/E Ratio (ttm) | 61.1984 |
|---|---|
| Estimated P/E(12/2013) | 34.3110 |
| Relative P/E vs. KOSPI | 2.4045 |
| Earnings Per Share (KRW) (ttm) | 2,737.0000 |
| Est. EPS (KRW) (12/2013) | 4,881.8140 |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 1,387,086.88 |
| Shares Outstanding (M) | 8.28 |
| 30 Day Average Volume | 49,812 |
| Price/Book (mrq) | 3.6404 |
| Price/Sale (ttm) | 2.0554 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 128940
Company Profile & Key Executives for 128940
Hanmi Pharm. Company Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
| Lim Sung-KiChairman/Co-Rep Director | Lee Gwan-SunPresident/CEO/Co-Rep Director |
| Lim Chong-YoonPresident | Han Chang-HeeVice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
128940 News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page